Becker's Healthcare October 24, 2024
Alexandra Murphy

Independent pharmacies are fighting to stay profitable as pharmacy benefit managers favor big chains, KFF Health News reported Oct. 24.

Here are four things to know:

  1. PBMs, the middlemen managing most U.S prescriptions, have faced scrutiny for allegedly inflating drug prices and reducing reimbursements for smaller pharmacies.
  2. This year, some Georgia pharmacists hoped state lawmakers would pass legislation that would level the playing field by increasing reimbursements for independent pharmacies. However, Gov. Brian Kemp vetoed the bill, citing a projected...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Pharma, Pharma / Biotech
Related Articles:
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers

Share This Article